Correlation analysis between COVID-19 disease severity and clinical and biochemical parameters in a rural tertiary care hospital of central Maharashtra, India

Laboratory parameter in COVID-19 infection




COVID-19, Correlation Analysis, Laboratory Parameters, Prognosis


BACKGROUND: The novel coronavirus (COVID-19) infection continues to wreak havoc across the developed world and now seems to have gained a strong foothold in developing countries including India. The mortality rate in severe/critically ill patients with COVID-19 is high. The present study was conducted to analyze the clinical and laboratory markers that discriminate severe/critically ill patients from those with mild/moderate COVID infection early for better clinical management of the disease.

METHODS: This laboratory-based, cross-sectional study was conducted on 517 confirmed cases of COVID-19 disease. The patients were divided into mild/moderate and severe/critical groups. Correlation analysis between COVID-19 disease severity and clinical and biochemical parameters was performed on the confirmed COVID-19 infection patients admitted to Shri Vasantrao Naik Government Medical College, Yavatmal, from March 15, 2020, to July 20, 2020. The Pearson correlation coefficient was used for the variables with normal distribution. Cut-off values for critically ill patients were speculated through the receiver-operating characteristics (ROC) curve.

RESULTS: The study population included 517 confirmed cases of COVID-19 infection. The median age of the patients was 34 years (IQR: 22–47; range: 18-64 years), with a male to female ratio of 1.2:1. Moreover, 176 (34.04%) patients had one or more co-morbidities, and hypertension (11.5%) and diabetes mellitus (DM‎) (10.44%) were the most common coexisting co-morbidities. A significant difference was observed between the mild/moderate group and severe/critically ill patients group in the laboratory parameters of serum ferritin, D-dimer, CRP, LDH, prolactin, albumin, ionic calcium, cTnI, and IL6.

CONCLUSION: Clinicians should consider age, co-morbidities, and laboratory parameters like lymphopenia, elevated D-dimer levels, elevated CRP, IL6, serum ferritin, cTnI, and


Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020; 25(5): 2000062.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020; 395(10229): 1054-62.

Ministry of Health and Family Welfare, Government of India. Clinical Management Protocol Covid-19 Version 4 updated 27-6-2020 [Online]. [cited 2020 June 2020]; Available from: URL:

Government of India, Ministry of Health and Family Welfare. Revised guidelines for Home Isolation of very mild/pre-symptomatic COVID-19 cases [Online]. [cited 2020 May 10]; Available from: URL:

Bhandari S, Bhargava A, Sharma S, Keshwani P, Sharma R, Banerjee S. Clinical profile of Covid-19 infected patients admitted in a tertiary care hospital in North India. J Assoc Physicians India. 2020; 68(5): 13-7.

WHO Health Organization. WHO Coronavirus (COVID-19) Dashboard [Online]. [cited 2020 Oct 27]; Available from: URL:

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8): 727-33.

Wang D, Li R, Wang J, Jiang Q, Gao C, Yang J, et al. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: A descriptive study. BMC Infect Dis. 2020; 20(1): 519.

Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A meta-analysis. Clin Chem Lab Med. 2020; 58(7): 1021-8.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061-9.

Sharma AK, Ahmed A, Baig VN, Dhakar P, Dalela G, Kacker S, et al. Characteristics and outcomes of hospitalized young adults with mild Covid -19. J Assoc Physicians India. 2020; 68(8): 62-5.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020; 395(10223): 507-13.

Gupta S. The age and sex distribution of COVID-19 cases and fatalities in India. medRxiv. 2020.

Singh AK, Misra A. Impact of COVID-19 and comorbidities on health and economics: Focus on developing countries and India. Diabetes Metab Syndr. 2020; 14(6): 1625-30.

Gupta N, Agrawal S, Ish P, Mishra S, Gaind R, Usha G, et al. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Arch Chest Dis. 2020; 90(1).

Sharma R, Daga MK, Mawari G, Karra VK, Kumar N, Jha MK, Kumar S. Global trends of clinical presentation of COVID-19. Indian J Med Spec 2020;11:59-64. 2022.

Henry BM. COVID-19, ECMO, and lymphopenia: A word of caution. Lancet Respir Med. 2020; 8(4): e24.

Devanandan P, Puvvada RC, Muthukumar VA. Lymphopenia as a marker for disease severity in COVID-19 patients: A metaanalysis. Asian Pac J Trop Med. 2020; 13: 426-8. 2022.

Aggarwal M, Dass J, Mahapatra M. Hemostatic abnormalities in COVID-19: An update. Indian J Hematol Blood Transfus. 2020; 36(4): 616-26.

Velavan TP, Meyer CG. Mild versus severe COVID-19:

Laboratory markers. Int J Infect Dis. 2020; 95: 304-7.

Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5): 846-8.

Sahu BR, Kampa RK, Padhi A, Panda AK. C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection. Clin Chim Acta. 2020; 509: 91-4.

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395(10229): 1033-4.

Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020; 63(3): 390-1.

Shah P, Doshi R, Chenna A, Owens R, Cobb A, Ivey H, et al. prognostic value of elevated cardiac troponin i in hospitalized Covid-19 patients. Am J Cardiol. 2020; 135: 150-3.

Pei G, Zhang Z, Peng J, Liu L, Zhang C, Yu C, et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol. 2020; 31(6): 1157-65.

Cappellini F, Brivio R, Casati M, Cavallero A, Contro E, Brambilla P. Low levels of total and ionized calcium in blood of COVID-19 patients. Clin Chem Lab Med. 2020; 58(9): e171-e173.

Zhou Y, Frey TK, Yang JJ. Viral calciomics: interplays between Ca2+ and virus. Cell Calcium. 2009; 46(1): 1-17.




How to Cite

Bhalavi V, Soyam G, Telgote D, Atram M, Pakhale M, Dharme P. Correlation analysis between COVID-19 disease severity and clinical and biochemical parameters in a rural tertiary care hospital of central Maharashtra, India: Laboratory parameter in COVID-19 infection. Chron Dis J. 2022;10(4):203–212.



Original Article(s)